Company news

Capricor Therapeutics, Inc. (NASDAQ:CAPR) news

Capricor Therapeutics, Inc. news releases on 6ix. Latest, Oct 5, 2026: Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb…

Capricor Therapeutics, Inc. (NASDAQ:CAPR) news

Press releases & updates

Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress

Capricor Therapeutics, Inc. (CAPR) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 28, 2026

CAPR DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - CAPR

Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 28, 2026 Deadline

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

CAPR Investor Reminder: Capricor Therapeutics Securities Fraud Class Action after 64% Stock Drop is Pending - Investors Notified to Contact BFA Law before September 28 Deadline

SEPTEMBER 28, 2026 CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Class Action Lawsuit Filed: Capricor Therapeutics, Inc. (CAPR) - Join by September 28, 2026 - Contact Levi & Korsinsky

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Contact Levi & Korsinsky to Join Class Action Before September 28, 2026

Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. - CAPR

Investors Urged to Contact Levi & Korsinsky for Information Before September 28, 2026 - Capricor Therapeutics, Inc. (CAPR)

Kaplan Fox Class Action Reminder: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Lead Plaintiff Deadline is September 28, 2026

SHAREHOLDER REMINDER: Berger Montague Reminds Capricor Therapeutics, Inc. (CAPR) Investors of the September 28, 2026 Deadline

CAPRICOR DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

CAPR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026

CAPR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

CAPR IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

CAPR DEADLINE NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

CAPR DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

CAPR DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

CAPR DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

CAPR DEADLINE: ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

ROSEN, A LEADING LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026

Securities Lawsuit Alert: Capricor Therapeutics, Inc. (CAPR) Investors - Contact Levi & Korsinsky Before September 28, 2026

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Urged to Join Class Action Before September 28, 2026 - Contact Levi & Korsinsky

Join Class Action to Recover Losses from Capricor Therapeutics, Inc. (CAPR) - Contact Levi & Korsinsky Before September 28, 2026

Pomerantz LLP Issues Reminder to Investors in Capricor Therapeutics, Inc. of Class Action Filing - CAPR

Capricor Therapeutics, Inc. (CAPR) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before September 28, 2026 Lead Plaintiff Deadline

Shareholders of Capricor Therapeutics, Inc. (CAPR): Protect Your Rights Before September 28, 2026 - Contact Levi & Korsinsky

Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA

INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Securities Fraud Class Action Lawsuit Filed; September 28, 2026, Lead Plaintiff Deadline

Levi & Korsinsky Notifies Capricor Therapeutics, Inc. (CAPR) Investors - Lead Plaintiff Deadline on September 28, 2026

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Join Class Action Before September 28, 2026 - Contact Levi & Korsinsky

CAPR ALERT: Securities Fraud Class Action Launched Against Capricor Therapeutics, Inc. - September 28, 2026 Deadline

Securities Lawsuit Alert: Capricor Therapeutics, Inc. (CAPR) - Contact Levi & Korsinsky Before September 28, 2026

Pomerantz LLP Alerts Shareholders to Investor Suit Against Capricor Therapeutics, Inc. - CAPR

CAPR Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages CAPR Investors with Losses to Contact the Firm

Securities Fraud Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) - Levi & Korsinsky Reminds Investors of September 28, 2026

September 28, 2026 Deadline Approaching: Join Class Action Against Capricor Therapeutics, Inc. (CAPR) - Contact Levi & Korsinsky

Did You Lose Money on Capricor Therapeutics, Inc. (CAPR)? Levi & Korsinsky Urges Investors to Act Before September 28, 2026

Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Class Action Alert: Levi & Korsinsky Reminds Capricor Therapeutics, Inc. (CAPR) Investors of September 28, 2026 Deadline

Kaplan Fox Reminds Capricor Therapeutics, Inc. (CAPR) Investors Seeking Recovery of the Lead Plaintiff Deadline on September 28, 2026

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Securities Class Action Lawsuit Filed Against Capricor Therapeutics, Inc. (CAPR) - Levi & Korsinsky Represents Shareholders

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

Levi & Korsinsky Urges Capricor Therapeutics, Inc. (CAPR) Shareholders to Act Before Lead Plaintiff Deadline September 28, 2026